trending Market Intelligence /marketintelligence/en/news-insights/trending/zcQDKovSDoeL4jQE_-BIpA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Fluidigm closes $63.3M common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Fluidigm closes $63.3M common stock offering

Fluidigm Corp. closed its underwritten public offering of 9,372,500 common shares at $6.75 apiece for gross proceeds of about $63.3 million.

The shares sold include the full exercise of the underwriters' option to buy up to 1,222,500 additional shares.

Net proceeds from the offering were approximately $59.1 million after deducting underwriting discounts and commissions and the estimated expenses of the offering.

The South San Francisco, Calif.-based mass cytometry and microfluidics technologies company intends to use the net proceeds for general corporate purposes, including working capital, capital expenditures and continued research and development with respect to products and technologies, and to fund possible investments in or acquisitions of complementary businesses, products or technologies.

Piper Jaffray and UBS Investment Bank acted as joint book-running managers for the offering, while BTIG and Janney Montgomery Scott acted as co-managers.